Repositorio digital RUNA

    • Español
    • Galego
    • English
  • Español 
    • Español
    • Galego
    • English
  • Login
RUNABibliosaúdeXunta de galicia. Consellería de sanidadeServicio Galego de saúde
  • REPOSITORIO
  • SOBRE NOSOTROS
    • Sobre RUNA
    • Normativa
    • Política Sergas
  • AYUDA
    • Ayuda
    • FAQ
  •   RUNA Principal
  • Publicación científica
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.

Runs of homozygosity and testicular cancer risk

Loveday, C.; Sud, A.; Litchfield, K.; Levy, M.; Holroyd, A.; Broderick, P.; Kote-Jarai, Z.; Dunning, A. M.; Muir, K.; Peto, J.; Eeles, R.; Easton, D. F.; Dudakia, D.; Orr, N.; Pashayan, N.; Rustin, G.; Srihari, N. N.; Cole, D.; Askill, C.; Bertelli, G.; Barber, J.; Gilby, E.; White, J.; Baybrooke, J.; Leahy, M.; Welch, R.; Chakraborti, P.; Joffe, J.; Brown, R.; Faust, G.; Simmonds, P.; Mazhar, D.; Stockdale, A.; Hrounda, D.; Humber, C.; Appel, W.; Hong, A.; Howard, G.; Douglas, F.; Bloomfield, D.; Butt, M.; Kelly, K.; Mehra, R.; Rogers, P.; Hatton, M.; Hennig, I.; McAteer, J.; Savage, P.; Seckl, M.; Gale, J.; Clark, P.; Woby, S.; Rathmell, A.; Lamont, A.; Sarwar, N.; Stuart, N.; Chowdhury, S.; Beesley, S.; Winkler, M.; Hamid, A.; Pathak, S.; Madhavan, K.; Highley, M.; Money-Kryle, J.; Brock, C.; Sreenivasan, T.; Henderson, B. E.; Haiman, C. A.; Schumacher, F. R.; Al Olama, A. A.; Benlloch, S.; Berndt, S. I.; Conti, D. V.; Wiklund, F.; Chanock, S.; Gapster, S.; Stevens, V. L.; Tangen, C. M.; Batra, J.; Clements, J.; Gronberg, H.; Schleutker, J.; Albanes, D.; Wolk, A.; West, C.; Mucci, L.; Cancel-Tassin, G.; Koutros, S.; Sorensen, K. D.; Maehle, L.; Neal, D. E.; Hamdy, F. C.; Donovan, J. L.; Travis, R. C.; Hamilton, R. J.; Ingles, S. A.; Rosenstein, B. S.; Lu, Y. J.; Giles, G. G.; Kibel, A. S.; Vega Gliemmo, Ana; Kogevinas, M.; Penney, K. L.; Park, J. Y.; Stanford, J. L.; Cybulski, C.; Nordestgaard, B. G.; Brenner, H.; Maier, C.; Kim, J.; John, E. M.; Teixeira, M. R.; Neuhausen, S. L.; Ruyck, K.; Razack, A.; Newcomb, L. F.; Lessel, D.; Kaneva, R.; Usmani, N.; Claessens, F.; Townsend, P. A.; Gago Dominguez, Manuela; Roobol, M. J.; Menegaux, F.; Khaw, K. T.; Cannon-Albrigh, L.; Pandha, H.; Thibodeau, S. N.; Reid, A.; Huddart, R. A.; Houlston, R. S.; Turnbull, C.
Thumbnail
Estadísticas
Estadísticas
Ver Estadísticas de uso
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/15675
PMID: 31310061
DOI: 10.1111/andr.12667
ISSN: 2047-2919
Registro completo
Servicios
Servicios
RISMendeleyLinksolver
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Andrology. 2019 Jul;7(4):555-564 (259.5Kb)
Acceso a la versión del editor (120.2Kb)
Autor corporativo
UK Testicular Cancer Collaboration; PRACTICAL Consortium
Fecha de publicación
2019
Título de revista
ANDROLOGY
Tipo de contenido
Artigo
DeCS
neoplasias testiculares | homocigoto | genotipo | genoma | factores de riesgo | humanos | estudio de asociación genómica completa | neoplasias
MeSH
Risk Factors | Humans | Genome | Testicular Neoplasms | Genome-Wide Association Study | Genotype | Neoplasms | Homozygote
Resumen
BACKGROUND: Testicular germ cell tumour (TGCT) is highly heritable but > 50% of the genetic risk remains unexplained. Epidemiological observation of greater relative risk to brothers of men with TGCT compared to sons has long alluded to recessively acting TGCT genetic susceptibility factors, but to date none have been reported. Runs of homozygosity (RoH) are a signature indicating underlying recessively acting alleles and have been associated with increased risk of other cancer types. OBJECTIVE: To examine whether RoH are associated with TGCT risk. METHODS: We performed a genome-wide RoH analysis using GWAS data from 3206 TGCT cases and 7422 controls uniformly genotyped using the OncoArray platform. RESULTS: Global measures of homozygosity were not significantly different between cases and controls, and the frequency of individual consensus RoH was not significantly different between cases and controls, after correction for multiple testing. RoH at three regions, 11p13-11p14.3, 5q14.1-5q22.3 and 13q14.11-13q.14.13, were, however, nominally statistically significant at p < 0.01. Intriguingly, RoH200 at 11p13-11p14.3 encompasses Wilms tumour 1 (WT1), a recognized cancer susceptibility gene with roles in sex determination and developmental transcriptional regulation, processes repeatedly implicated in TGCT aetiology. DISCUSSION AND CONCLUSION: Overall, our data do not support a major role in the risk of TGCT for recessively acting alleles acting through homozygosity, as measured by RoH in outbred populations of cases and controls.

Navega

Todo RUNAColeccionesCentrosAutoresTítulosDeCSMeSHCIETipos de contenidosEsta colecciónCentrosAutoresTítulosDeCSMeSHCIETipos de contenidos

Estadísticas

Ver Estadísticas de uso

DE INTERÉS

Sobre Acceso AbiertoDerechos de autor
TwitterRSS
Xunta de Galicia
© Xunta de Galicia. Información mantida e publicada na internet pola Consellería de Sanidade o Servizo Galego de Saúde
Aviso legal | RSS
Galicia